Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Non-Current Deffered Revenue (2016 - 2025)

Healthcare Services (HCSG) has disclosed Non-Current Deffered Revenue for 17 consecutive years, with $56.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Deffered Revenue rose 12.53% to $56.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $56.3 million, a 12.53% increase, with the full-year FY2025 number at $56.3 million, up 12.53% from a year prior.
  • Non-Current Deffered Revenue was $56.3 million for Q4 2025 at Healthcare Services, up from $55.6 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $56.3 million in Q4 2025 to a low of $31.8 million in Q3 2022.
  • A 5-year average of $44.1 million and a median of $46.5 million in 2024 define the central range for Non-Current Deffered Revenue.
  • Peak YoY movement for Non-Current Deffered Revenue: surged 55.74% in 2021, then plummeted 37.32% in 2022.
  • Healthcare Services' Non-Current Deffered Revenue stood at $46.9 million in 2021, then fell by 27.99% to $33.8 million in 2022, then rose by 21.98% to $41.2 million in 2023, then rose by 21.43% to $50.0 million in 2024, then increased by 12.53% to $56.3 million in 2025.
  • Per Business Quant, the three most recent readings for HCSG's Non-Current Deffered Revenue are $56.3 million (Q4 2025), $55.6 million (Q3 2025), and $51.7 million (Q2 2025).